|
| 33422603 | Substituted diaryl ether compounds as retinoic acid-related orphan Receptor-γt (RORγt) agonists. | Bioorg Med Chem Lett | 2021 |
| 33822623 | Discovery and Optimization of 2<i>H</i>-1λ<sup>2</sup>-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer. | J Med Chem | 2021 |
| 33422603 | Substituted diaryl ether compounds as retinoic acid-related orphan Receptor-γt (RORγt) agonists. | Bioorg Med Chem Lett | 2021 |
| 34408078 | The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia. | Sci Transl Med | 2021 |
| 33822623 | Discovery and Optimization of 2<i>H</i>-1λ<sup>2</sup>-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer. | J Med Chem | 2021 |
| 34408078 | The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia. | Sci Transl Med | 2021 |
| 32192654 | Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction. | J Am Coll Cardiol | 2020 |
| 32203152 | Multiplexed ion beam imaging (MIBI) for characterization of the tumor microenvironment across tumor types. | Lab Invest | 2020 |
| 32192654 | Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction. | J Am Coll Cardiol | 2020 |
| 31843232 | Effect of Serum Albumin Levels in Patients With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial). | Am J Cardiol | 2020 |
| 31926856 | Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone. | JACC Heart Fail | 2020 |
| 32089075 | Circulating and tissue matricellular RNA and protein expression in calcific aortic valve disease. | Physiol Genomics | 2020 |
| 32873881 | Quantifying drug tissue biodistribution by integrating high content screening with deep-learning analysis. | Sci Rep | 2020 |
| 32803990 | Plasma Tenascin-C: a prognostic biomarker in heart failure with preserved ejection fraction. | Biomarkers | 2020 |
| 32089075 | Circulating and tissue matricellular RNA and protein expression in calcific aortic valve disease. | Physiol Genomics | 2020 |
| 31843232 | Effect of Serum Albumin Levels in Patients With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial). | Am J Cardiol | 2020 |
| 31926856 | Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone. | JACC Heart Fail | 2020 |
| 32803990 | Plasma Tenascin-C: a prognostic biomarker in heart failure with preserved ejection fraction. | Biomarkers | 2020 |
| 32873881 | Quantifying drug tissue biodistribution by integrating high content screening with deep-learning analysis. | Sci Rep | 2020 |
| 32203152 | Multiplexed ion beam imaging (MIBI) for characterization of the tumor microenvironment across tumor types. | Lab Invest | 2020 |
| 29248646 | Symptom Onset in Aortic Stenosis: Relation to Sex Differences in Left Ventricular Remodeling. | JACC Cardiovasc Imaging | 2019 |
| 29248646 | Symptom Onset in Aortic Stenosis: Relation to Sex Differences in Left Ventricular Remodeling. | JACC Cardiovasc Imaging | 2019 |
| 30972180 | Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotype. | Am J Transl Res | 2019 |
| 30898214 | Soluble FMS-Like Tyrosine Kinase-1 Is a Circulating Biomarker Associated With Calcific Aortic Stenosis. | J Am Coll Cardiol | 2019 |
| 31308926 | Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes. | Ther Adv Endocrinol Metab | 2019 |
| 31308926 | Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes. | Ther Adv Endocrinol Metab | 2019 |
| 30898214 | Soluble FMS-Like Tyrosine Kinase-1 Is a Circulating Biomarker Associated With Calcific Aortic Stenosis. | J Am Coll Cardiol | 2019 |
| 30972180 | Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotype. | Am J Transl Res | 2019 |
| 29555419 | Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors. | Bioorg Med Chem | 2018 |
| 29877628 | Assay Guidance Manual: Quantitative Biology and Pharmacology in Preclinical Drug Discovery. | Clin Transl Sci | 2018 |
| 29555419 | Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors. | Bioorg Med Chem | 2018 |
| 29877628 | Assay Guidance Manual: Quantitative Biology and Pharmacology in Preclinical Drug Discovery. | Clin Transl Sci | 2018 |
| 26838815 | Erratum: Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy. | Nat Commun | 2016 |
| 26838815 | Erratum: Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy. | Nat Commun | 2016 |
| 27428418 | A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and Genetics. | EBioMedicine | 2016 |
| 26341717 | A high-content imaging-based screening pipeline for the systematic identification of anti-progeroid compounds. | Methods | 2016 |
| 27681596 | Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models. | J Biol Chem | 2016 |
| 27552339 | Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors. | ACS Chem Biol | 2016 |
| 26341717 | A high-content imaging-based screening pipeline for the systematic identification of anti-progeroid compounds. | Methods | 2016 |
| 27681596 | Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models. | J Biol Chem | 2016 |
| 27428418 | A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and Genetics. | EBioMedicine | 2016 |
| 27552339 | Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors. | ACS Chem Biol | 2016 |
| 25653139 | Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy. | Nat Commun | 2015 |
| 25653139 | Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy. | Nat Commun | 2015 |
| 25945839 | Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis. | Oncotarget | 2015 |
| 25944801 | Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer. | Clin Cancer Res | 2015 |
| 25940539 | Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer. | Oncotarget | 2015 |
| 26260604 | High-Throughput Screening for Allosteric Modulators of GPCRs. | Methods Mol Biol | 2015 |
| 26260604 | High-Throughput Screening for Allosteric Modulators of GPCRs. | Methods Mol Biol | 2015 |
| 25945839 | Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis. | Oncotarget | 2015 |